Rituximab - la Neurologia Italiana

Ricerca
Congressi
Associazioni
Aziende
Demenze
Parkinsonismi
Sclerosi multipla
Cefalee
Ictus
altro
Cerca
Cerca

Rituximab nella lista 648 per la neuromielite ottica

L’AIFA ha autorizzato la rimborsabilità del farmaco a carico del Servizio sanitario nazionale Da oggi i pazienti affetti da neuromielite ottica, o malattia di Devic, potranno curarsi a carico del Servizio sanitario nazionale. L'AIFA ha…

31 Gennaio 2018

Newsletter

Iscriviti alla nostra newsletter
Due invii al mese, un click per cancellarsi.

Vedi le Newsletter inviate

Abbonamento

Abbonati alla rivista

Categorie articoli

MeP Edizioni 2020

Home
Chi siamo
Iscrizione newsletter

Questo sito usa cookie propri e di terze parti per migliorare la navigazione OK - va bene leggi i dettagli

privacy & cookies

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessario

Sempre attivato

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non necessario

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.